HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jens Kjeldsen-Kragh Selected Research

human ITGB3 protein (HPA-1a)

10/2020Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
1/2020Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome.
1/2019HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women.
1/2019Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
1/2017Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study.
1/2012The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jens Kjeldsen-Kragh Research Topics

Disease

13Neonatal Alloimmune Thrombocytopenia
05/2022 - 06/2008
6Thrombocytopenia (Thrombopenia)
10/2020 - 06/2008
5Hemorrhage
07/2020 - 10/2005
2Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2022 - 01/2017
1COVID-19
01/2022
1Virus Diseases (Viral Diseases)
12/2021
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2016
1IgA Deficiency
10/2015
1Bone Marrow Diseases (Bone Marrow Disease)
06/2015
1Nervous System Diseases (Neurological Disorders)
05/2013
1Birth Weight (Birth Weights)
01/2012
1Purpura
08/2007
1Hemolysis
08/2007
1Thrombocytopenic Purpura (Thrombopenic Purpura)
04/2003
1Lymphopenia (Lymphocytopenia)
12/2002

Drug/Important Bio-Agent (IBA)

13AntibodiesIBA
05/2022 - 04/2003
6human ITGB3 protein (HPA-1a)IBA
10/2020 - 01/2012
4AntigensIBA
05/2022 - 01/2012
4HLA-DRB3 Chains (HLA DRB3)IBA
10/2020 - 01/2019
4Human Platelet AntigensIBA
07/2020 - 04/2003
3Intravenous Immunoglobulins (IVIG)FDA Link
01/2022 - 01/2017
3IsoantibodiesIBA
01/2022 - 01/2012
1Immunoglobulin G (IgG)IBA
05/2022
1Rituximab (Mabthera)FDA Link
01/2022
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2017
1Platelet Membrane GlycoproteinsIBA
02/2016
1Inosine Triphosphate (ITP)IBA
02/2016
1Proteins (Proteins, Gene)FDA Link
10/2015
1Immunoglobulin A (IgA)IBA
10/2015
1Pharmaceutical PreparationsIBA
06/2015
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
06/2015
1Histone Deacetylases (Histone Deacetylase)IBA
05/2013
1ABO Blood-Group SystemIBA
01/2012
1SolutionsIBA
08/2007
12,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)IBA
10/2005
1Hydrocortisone (Cortisol)FDA LinkGeneric
12/2002
1Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2002
1Epinephrine (Adrenaline)FDA LinkGeneric
12/2002
1Adrenocorticotropic Hormone (ACTH)FDA Link
12/2002
1Growth Hormone (Somatotropin)IBA
12/2002

Therapy/Procedure

1Therapeutics
12/2021
1Blood Transfusion (Blood Transfusions)
10/2015
1Stem Cell Transplantation
06/2015
1Cesarean Section (Caesarean Section)
08/2007